Offer An Article

Pandemic Latest News

Press

Thalassemia Patients Group call for inclusion of patients in policy making at APPIS 2021

New Delhi, 3rd March 2021 – Thalassemia Patients Advocacy Group (TPAG) stressed the importance of involving patients in the policy making at the ongoing Asia Pacific Patient Innovation Summit (APPIS), a unique collaborative partnership initiated to address the evolving capability needs of patient organizations across Asia Pacific and beyond. Themed “Co-creating patient advocacy of the …

Thalassemia Patients Group call for inclusion of patients in policy making at APPIS 2021 Read More »

Racefor7 – Raising awareness and de-stigmatizing rare diseases in India

Event to be held virtually this year across the country united by a live broadcast from Bangalore   This year Racefor7 hopes to break the stigma and silence about rare diseases 24th February 2021, Bangalore: In the backdrop of Rare Disease Day 2021, Organization for Rare Diseases India (ORDI) a not for profit organization representing the …

Racefor7 – Raising awareness and de-stigmatizing rare diseases in India Read More »

Tata STRIVE and Wipro GE Healthcare partner to train youth towards bridging healthcare skill gap in the country

Program aims to skill 6,000+ youth with a focus on candidates from underserved backgrounds Tata STRIVE to provide loan scholarships to deserving candidates with the support of Tata Trusts Wipro GE Healthcare developed technical training courses to be undertaken across the country with the network of its partner institutes and technical support of Tata STRIVE …

Tata STRIVE and Wipro GE Healthcare partner to train youth towards bridging healthcare skill gap in the country Read More »

Dr. Reddy’s Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. February 22, 2021— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Lansoprazole DR Orally Disintegrating Tablets  a therapeutic equivalent generic version of Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets, 15 mg …

Dr. Reddy’s Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market Read More »

Hunjan Hospital launches Mako Robotic Arm-Assisted Technology for knee replacement in Ludhiana

Feb 20, 2021 | Ludhiana: Ludhiana reached an important milestone in knee replacement as it became the first city in Northern India to have the world’s most widely adopted US FDA approved Mako Robotic Arm-Assisted Technology. The first Mako System in Northern India has been installed at Hunjan Hospital, said a press release issued jointly …

Hunjan Hospital launches Mako Robotic Arm-Assisted Technology for knee replacement in Ludhiana Read More »

All you need to know about Breast Cancer

World Cancer Day 2021: All you need to know about Breast Cancer The most common cancer amongst women, breast cancer covers 25% of all cancer burden, globally as well as in India. With alarming rise in its incidence in the country, predominantly in urban India, estimates suggest every four minutes an Indian woman is diagnosed …

All you need to know about Breast Cancer Read More »

Wolters Kluwer and ICC accentuate the need of Evidence-Based Medicine practice to provide quality care

Virtual conference on the need to adopt technologically integrated EBM practice Today’s healthcare ecosystem needs to be technologically integrated for clinicians to provide standardized care to their patient for better outcomes. The Covid-19 pandemic has brought a great havoc to the world, but it has been a driving force in adoption of digital technologies which …

Wolters Kluwer and ICC accentuate the need of Evidence-Based Medicine practice to provide quality care Read More »

A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet

In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity and safety results. Efficacy of Sputnik V against COVID-19 was reported at 91.6%. Analysis included data on 19,866 volunteers, who received both the first and second doses of the Sputnik V vaccine or placebo at the final control point …

A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet Read More »

Novartis renews WHO medicine donation pledge with aim of ending leprosy

Novartis leprosy medicine donation program with WHO extended to 2025 Program has already treated over 7 million patients since 2000 New evidence from contact tracing and preventive treatment program shows route to accelerate elimination  Basel, January 29, 2021 — A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the …

Novartis renews WHO medicine donation pledge with aim of ending leprosy Read More »

Health insurance policies to cover Peritoneal Dialysis to reduce dialysis burden in India

To address the increasing number of Kidney Failure patients in India, the Insurance Regulatory Development Authority of India (IRDAI) has released the much-awaited policy guidelines to include Peritoneal Dialysis (PD)in the ambit of private insurance coverage. According to the guidelines, patients taking treatment of PD can make reimbursement claims on a monthly basis through an …

Health insurance policies to cover Peritoneal Dialysis to reduce dialysis burden in India Read More »